Considering that IL6 and TNFα have a close interaction and play essential roles in inflammatory response and cancer long-term outcomes, the combination of them seems to be a potentially more accurate, predictive, and sensitive indicator for predicting cancer prognosis. The gene discussed is IL6; the disease is cancer.